Founder of the Month September: OPASCA GmbH

OPASCA Logo_180OPASCA has specialized in the development of intelligent, sensor-based systems and solutions for environment detection. On the basis of a diverse and flexible platform concept, customer-tailored solutions are realized in the areas of person and object detection for a large range of applications. The technology is used primarily in the field of radiotherapy. The focus lies on the wellbeing of patients and the support of the professional staff. In an interview, we asked the team of OPASCA about the idea, the startup time, and the future prospects.

Gründerteam von OPASCA: Dr. Timo Machmer, Steffen Liebscher und Dr. Alexej Swerdlow

Founderteam of OPASCA: Dr. Timo Machmer, Steffen Liebscher and Dr. Alexej Swerdlow

Continue reading

Investment success for KIT spin-off amcure GmbH

The KIT spin-off amcure GmbH receives funding of five million euro for the development of new anticancer drugs. The LBBW Venture Capital GmbH in Stuttgart invests in this scientific spin-off. Other investors, such as the KfW-Bank and the Federal Ministry of Education and Research (BMBF), are also participating in the investments.

There is urgent medical need for the treatment of metastasizing kinds of tumors. In the case of pancreatic cancer, an aggressive kind of cancer which is often discovered late, 95 per cent of the patients die within five years of the diagnosis. The KIT spin-off amcure developed tumor drugs which could lower this rate. For the pre-clinical and clinical tests of the drugs amcure now collected a total of five million euro. With this funding, amcure will further develop its product candidate AM001 for the treatment of cancer in the next years and push their active substance forward to the clinical level.

Congratulations on the funding to the team of amcure! We wish you great success for the further development of the tumor medicine!

Extensive press information at: